Products / Liraglutide

LIRAGLUTIDE labelled vial

Liraglutide 5 mg

A structurally modified GLP-1 analogue studied in receptor signalling and metabolic research.

CAD $81.00 / vial

Vial amount

Add to cart Ask about this product

The specifics, clearly listed.

Product details

Product reference: MRD-0096 Listed amount per vial: 5 mg Sales unit: 1 vial

Read the research in context.

A structurally modified GLP-1 analogue studied in receptor signalling and metabolic research.

  • LIRAGLUTIDE injection, solution: Orbicular Pharmaceutical Technologies label — source

Candidate-molecule or reference-product background; not verification of this supplied product.

What this doesn’t establish: Exact sequence, acylation/linker, salt and active amount require supplier verification. Exact supplied identity/form, measured amount, lot-linked quality reports, purity, sterility/endotoxin, storage/stability and authorization are not established by these references.

Product documents

No verified report is available here for this item. Ask about documentation for Liraglutide, product reference MRD-0096.

Before you decide.

Separate research about the compound from evidence about the supplied product.

Which vial amount is shown?

This listing shows 5 mg per vial.

Does the study verify this vial?

No. Research on a compound does not establish the identity, quality, safety or effectiveness of a product sold under that name.

What should I check in a report?

Check the sample identity, batch reference, issuer, date, test methods and results. A report applies to the identified sample and tests.

What information should I request?

Ask about the exact product identity, form, specification, handling requirements and relevant batch documents before deciding.